Newly Diagnosed Acute Myeloid Leukemia Aml clinical trials

Explore recruiting newly diagnosed acute myeloid leukemia aml clinical trials.

Recruiting newly diagnosed acute myeloid leukemia aml studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Newly Diagnosed Acute Myeloid Leukemia Aml trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Prospective randomized multicenter phase III trial of decitabine and venetoclax administered in combination with all-trans retinoic acid or placebo in patients with acute myeloid leukemia who are ineligible for induction chemotherapy - DECIDER-2 trial

Germany

Therapeutic confirmatory (Phase III) EU CTIS Study details

Venetoclax plus azacitidine versus standard intensive chemotherapy for patients with newly diagnosed acute myeloid leukemia (AML) and NPM1 mutations eligible for intensive treatment (VINCENT)

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Phase 3 Randomized, Double-blind, Placebo-controlled Studies Assessing Ziftomenib in Combination with Either Standard of Care Nonintensive (Venetoclax+Azacitidine) or Intensive (7+3) Therapy in Patients with Untreated NPM1 Mutated or KMT2A Rearranged Acute Myeloid Leukemia

Belgium, Spain, Italy, Czechia, Hungary, Poland +4 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Phase II study on Venetoclax (VEN) plus Decitabine (DEC) (VEN-DEC) for elderly (≥60 <75years) patients with newly diagnosed Acute Myeloid Leukemia (AML) elegible for allogeneic Stem Cell Transplantation (allo-SCT)

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

A first-in-human, two-part, open-label, clinical study to assess the safety, tolerability, and activity of intravenous doses of ICT01 as monotherapy and in combination with an immune checkpoint inhibitor, in patients with advanced-stage, relapsed/refractory cancer (EVICTION Study)

Belgium, France, Spain, Germany

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

HOVON 156 AML: A phase 3, multicenter, open-label, randomized, study of gilteritinib versus midostaurin in combination with induction and consolidation therapy followed by one-year maintenance in patients with newly diagnosed Acute Myeloid Leukemia (AML) or Myelodysplastic syndromes with excess blasts-2 (MDS-EB2) with FLT3 mutations eligible for intensive chemotherapy.

Lithuania, Austria, Germany, Ireland, Norway, Sweden +5 more

Therapeutic exploratory (Phase II) EU CTIS Study details

Newly Diagnosed Acute Myeloid Leukemia Aml trials by city

Newly Diagnosed Acute Myeloid Leukemia Aml in Toronto Newly Diagnosed Acute Myeloid Leukemia Aml in Vancouver Newly Diagnosed Acute Myeloid Leukemia Aml in Montreal Newly Diagnosed Acute Myeloid Leukemia Aml in Calgary Newly Diagnosed Acute Myeloid Leukemia Aml in Edmonton Newly Diagnosed Acute Myeloid Leukemia Aml in Ottawa Newly Diagnosed Acute Myeloid Leukemia Aml in Winnipeg Newly Diagnosed Acute Myeloid Leukemia Aml in Quebec City Newly Diagnosed Acute Myeloid Leukemia Aml in Hamilton Newly Diagnosed Acute Myeloid Leukemia Aml in Kitchener Newly Diagnosed Acute Myeloid Leukemia Aml in London Newly Diagnosed Acute Myeloid Leukemia Aml in Halifax Newly Diagnosed Acute Myeloid Leukemia Aml in New York Newly Diagnosed Acute Myeloid Leukemia Aml in Los Angeles Newly Diagnosed Acute Myeloid Leukemia Aml in Chicago Newly Diagnosed Acute Myeloid Leukemia Aml in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease